Abbott and Alere Amend Terms of Merger Agreement
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/25/2026
- Nasdaq lags on angst over AI spending ahead of earnings reports
- Elon Musk’s trillion-dollar meltdown: How SpaceX and Tesla erased $700 billion
- Intel jumps 10% after AI-fueled quarter crushes estimates, upbeat outlook
- Oil falls on report China pushing for end US-Iran war
- Why Meta, Microsoft, and Nvidia are championing open-weight AI
- FDA approves Tylenol with Naproxen as first OTC combo pain reliever
- AMD (AMD) PT Raised to $1,250 at Baird
- Pakistan, Iran explore path towards new talks with US in a China-initiated push, sources say
- Elon Musk’s trillion-dollar meltdown: How SpaceX and Tesla erased $700 billion
- Nasdaq lags on angst over AI spending ahead of earnings reports
Alere (ALR) PT Lowered to $51 at Canaccord Genuity
April 17, 2017 9:27 AM EDTCanaccord Genuity lowered its price target on Alere (NYSE: ALR) to $51.00 (from $52.00) while maintaining a Buy rating. ABT and ALR announced a settlement at $51/share, or ~21% higher than ALR's closing price of $42.31 last Thursday.
Canaccord believes that shareholders would have approved anything at $50+ so... More
Alere (ALR) PT Lowered to $51 at Jefferies Following Announced Revisions to ABT Merger
April 17, 2017 7:17 AM EDTJefferies lowered its price target on Alere (NYSE: ALR) to $51.00 (from $56.00) while maintaining a Hold rating following the company's announced amended the terms of to the merger with ABT.
Key revisions include: 1) $51/share vs. the original $56; 2) timeline extended to September 30 from April 30; and... More
